Stockreport

Ultragenyx Pharmaceutical Inc (RARE) Q3 2024 Earnings Call Highlights: Robust Revenue Growth ... [Yahoo! Finance]

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF CRISPRIDA Revenue: $98 million, with $56 million from North America, $36 million from Latin America and Turkey, and $6 million from Europe. Dojolvi Revenue: $21 milli [Read more]